Sign In

A subscription to JoVE is required to view this content. Sign in or start your free trial.

In This Article

  • Summary
  • Abstract
  • Introduction
  • Protocol
  • Representative Results
  • Discussion
  • Acknowledgements
  • Materials
  • References
  • Reprints and Permissions

Summary

This work describes the synthesis and characterization of a pomalidomide-based, bifunctional homo-PROTAC as a novel approach to induce ubiquitination and degradation of the E3 ubiquitin ligase cereblon (CRBN), the target of thalidomide analogs.

Abstract

The immunomodulatory drugs (IMiDs) thalidomide and its analogs, lenalidomide and pomalidomide, all FDA approved drugs for the treatment of multiple myeloma, induce ubiquitination and degradation of the lymphoid transcription factors Ikaros (IKZF1) and Aiolos (IKZF3) via the cereblon (CRBN) E3 ubiquitin ligase for proteasomal degradation. IMiDs have recently been utilized for the generation of bifunctional proteolysis targeting chimeras (PROTACs) to target other proteins for ubiquitination and proteasomal degradation by the CRBN E3 ligase. We designed and synthesized pomalidomide-based homobifunctional PROTACs and analyzed their ability to induce self-directed ubiquitination and degradation of CRBN. Here, CRBN serves as both, the E3 ubiquitin ligase and the target at the same time. The homo-PROTAC compound 8 degrades CRBN with a high potency with only minimal remaining effects on IKZF1 and IKZF3. CRBN inactivation by compound 8 had no effect on cell viability and proliferation of different multiple myeloma cell lines. This homo-PROTAC abrogates the effects of IMiDs in multiple myeloma cells. Therefore, our homodimeric pomalidomide-based compounds may help to identify CRBN‘s endogenous substrates and physiological functions and investigate the molecular mechanism of IMiDs.

Introduction

The immunomodulatory drugs (IMiDs) thalidomide and its analogs, lenalidomide and pomalidomide, all approved for the treatment of multiple myeloma, bind to the E3 ubiquitin ligase cereblon (CRBN), a substrate adaptor for cullin4A-RING E3 ubiquitin ligase (CRL4CRBN)1,2,3. Binding of IMiDs enhances the affinity of CRL4CRBN to the lymphoid transcription factors Ikaros (IKZF1) and Aiolos (IKZF3), leading to their ubiquitination and degradation (Figure 1)4,5,....

Protocol

1. Preparation of PROTAC molecules

CAUTION: Please consult all relevant material safety data sheets (MSDS) before use. Several of the chemicals used in these syntheses are toxic and carcinogenic. Please use all appropriate safety practices and personal protective equipment.

  1. Preparation of tert-butyl N-(2,6-dioxo-3-piperidyl)carbamate (compound 1)
    1. Add 1,1'-carbonyldiimidazole (1.95 g, 12 mmol) and a catalytic amount of 4-(dimethylam.......

Representative Results

Here we described the design, synthesis and biological evaluation of a homodimeric pomalidomide-based PROTAC for the degradation of CRBN. Our PROTAC interacts simultaneously with two CRBN molecules and forms ternary complexes that induces self-ubiquitination and proteasomal degradation of CRBN with only minimal remaining effects on pomalidomide-induced neo-substrates IKZF1 or IKZF3.

Out of a series of previously published pomali.......

Discussion

The design of such homo-PROTACs as described here for CRBN relies on the specific affinity of pomalidomide to CRBN, which has been successfully utilized in numerous heterobifunctional PROTACs and resulted in the development of PROTAC 8 as a highly selective CRBN degrader. The specificity of our molecule has already been confirmed by proteomic analyses24. For genetically mediated knockout, exclusion and validation of side effects is challenging and time consuming. In addition, a ch.......

Acknowledgements

This work was supported by the Deutsche Forschungsgemeinschaft (Emmy-Noether Program Kr-3886/2-1 and SFB-1074 to J.K.; FOR2372 to M.G.)

....

Materials

NameCompanyCatalog NumberComments
1,1'-CarbonyldiimidazoleTCI chemicalsC0119
2,2′-(Ethylenedioxy)-bis(ethylamine)Sigma-Aldrich385506Compound 6
2-MercaptoethanolSigma-AldrichM6250
3-Fluorophthalic anhydride, 98 %Alfa AesarA12275
4-Dimethylaminopyridine, 99 %Acros148270250Toxic
Acrylamidstammlösung/ Bisacrylamid (30%/0,8%)Carl Roth3029.1
Aiolos (D1C1E) mABCell signaling15103S
Anti-CRBN antibody produced in rabbitSigmaHPA045910
Anti-rabbit IgG HRP-linked antibodySigma7074S
Ammonium PersulfateRoth9592.2
Boc-Gln-OHTCI chemicalsB1649
Bovine Serum AlbuminSigma-AldrichA7906-100G
CellTiter-Glo Luminescent Cell Viability AssayPromegaG7571
ChemiDoc XRS+Bio-Rad1708265
DMF, anhydrous, 99.8 %Acros348435000Extra Dry over Molecular Sieve
DMSO, anhydrous, 99.7 %Acros348445000Extra Dry over Molecular Sieve
GlycineSigma-Aldrich15523-1L-R
Goat anti-mouse (HRP conjugated)Santa Cruz biotechnologysc-2005
Halt Protease & Phosphatase Inhibitor Single-use Cocktail (100X)Thermo Scientific1861280
Ikaros (D6N9Y) MabCell signaling14859S
ImmobilonP Transfer Membrane (0,45µm)MerckIPVH000010
Iodomethane, 99 %Sigma-AldrichI8507Highly toxic
MethanolSigma-Aldrich32213-2.5L
Mg132SelleckchemS2619
Mini Trans-Blot electrophoretic transfer cellBio-Rad1703930
Mini-PROTEAN Tetra Vertical Electrophoresis CellBio-Rad1658004
MLN4942biomol (cayman)Cay15217-1
Monoclonal Anti-α-Tubulin antibody produced in mouse (B512)SigmaT5168
N-Ethyldiisopropylamine, 99 %Alfa AesarA11801
Nonfat dried milk powderPanReac AppliChemA0830,0500
Nunc F96 MicroWell White Polystyrene PlateThermo Scientific136101
NuPAGE LDS Sample Buffer (4X)Thermo ScientificNP0008
Pierce BCA Protein Assay kitThermo Scientific23225
PomalidomideSelleckchemS1567
RestoreTM Western Blot Stripping BufferThermo Scientific46430
sodium dodecyl sulfateCarl Roth183.1
Sodium ChlorideSigma-AldrichA9539-500g
TEMEDCarl Roth2367.3
tert-Butyl N-[2-[2-(2-aminoethoxy)ethoxy]ethyl]carbamateSigma-Aldrich89761Compound 5
TricinCarl Roth6977.4
Trizma baseSigma-AldrichT1503-1kg
Tween-20Sigma-AldrichP7949-500ml
WesternBright ECL sprayAdvanstaK-12049-D50

References

  1. Ito, T., et al. Identification of a primary target of thalidomide teratogenicity. Science. 327 (5971), 1345-1350 (2010).
  2. Lopez-Girona, A., et al. Cereblon is a direc....

Explore More Articles

CRBN InhibitionPROTACPomalidomideCereblonE3 Ubiquitin LigaseProtein DegradationChemical SynthesisGlutarimide3 fluorophthalic AnhydrideDiamine Linker

This article has been published

Video Coming Soon

JoVE Logo

Privacy

Terms of Use

Policies

Research

Education

ABOUT JoVE

Copyright © 2024 MyJoVE Corporation. All rights reserved